Emergency Department-based Cervical Cancer Screening Through Self-sampling
Part of paid clinical trials in Rochester, New York.
- Sponsor
- University of Rochester
- Study ID
- NCT07345897
- Status
- Recruiting
Conditions
- Cervical Cancer (Early Detection)
- Cervical Cancer Screening
- HPV
- HPV Associated Cancers
- HPV Cancers
Eligibility Criteria
- Sex
- FEMALE
- Age
- 30 Years - 65 Years
- Healthy Volunteers
- Accepted
Interventions
- Cervical Cancer Screening — DIAGNOSTIC_TESTSubjects will perform self sampling for cervical cancer.
Study Details
This project will compare the uptake of cervical cancer screening through ED HPV sampling among patients presenting to the ED.
Key Dates
- Start date
- Feb 13, 2026
- Status verified
- Jan 2026
- Primary completion
- Aug 31, 2027
- Completion
- Jan 31, 2028
Study Design
- Enrollment
- 200 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- SCREENING
Arms
- Experimental: Intervention ArmParticipants will be provided the opportunity to self- sample for HPV during their ED visit. Participants will be (1) briefly instructed by study staff on how to self-sample using a defined instructional script written at an elementary reading level, (2) provided with a packaged swab, and (3) invited to self- sample privately in their ED room or in one of the private ED restrooms. Once self sampling has been completed, the study staff will then transfer the swab to a vial of transport media and forward the specimens to the laboratory for analysis. Participants recruited to the intervention arm that subsequently decline to or are unable to self-sample in the ED will remain in the study and will receive referral for clinic-based screening.
Primary Outcome Measure
Uptake of cervical cancer screening from self-sampling in the ED [ Time Frame: In about 150 days of enrollment ]
Central Contacts
- Research Administrator585-274-1509
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Rochester Strong Memorial Hospital | Rochester | New York | 14642 |
Find similar trials in Rochester, NY
By research site
Related Studies
- A Study on Using Cell-Free Tumor DNA (ctDNA) Testing to Decide When to StartRoutine Treatment in People With Human Papilloma Virus (HPV)- Associated Oropharynx Cancer (OPC)PHASE2 · Recruiting · Memorial Sloan Kettering Cancer Center · Miami, Florida
- A Study of Reduced Radiation Therapy and Standard-of-Care Chemotherapy in People With HPV-Positive Throat CancerPHASE2 · Recruiting · Memorial Sloan Kettering Cancer Center · Basking Ridge, New Jersey
- Real-world Effectiveness of HPV Vaccine in Women Living With HIV and Its Impact on Cervical Cancer Screening AccuraciesEnrolling By Invitation · University of California, Los Angeles · Denver, Colorado
- Stand Up 2 HPV: Standing Orders to Improve HPV VaccinationRecruiting · University of Rochester · Rochester, New York